Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Privia Health Group ( (PRVA) ) is now available.
On September 23, 2025, Privia Health Group announced its agreement to acquire an Accountable Care Organization business from Evolent Health for $100 million, with an additional $13 million contingent on performance. This acquisition, expected to close in the fourth quarter of 2025, will expand Privia Health’s value-based care arrangements to approximately 1.5 million attributed lives, enhancing its national network and offering synergy opportunities for participating providers.
The most recent analyst rating on (PRVA) stock is a Buy with a $33.00 price target. To see the full list of analyst forecasts on Privia Health Group stock, see the PRVA Stock Forecast page.
Spark’s Take on PRVA Stock
According to Spark, TipRanks’ AI Analyst, PRVA is a Outperform.
Privia Health Group’s overall stock score is driven by strong financial performance and positive earnings call insights. However, the high P/E ratio suggests potential overvaluation, and technical indicators imply caution due to overbought conditions.
To see Spark’s full report on PRVA stock, click here.
More about Privia Health Group
Privia Health is one of the largest physician enablement companies in the United States, operating in 15 states and the District of Columbia. It builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, and a physician-led governance structure, supported by the Privia Platform’s extensive suite of technology and service solutions.
Average Trading Volume: 957,236
Technical Sentiment Signal: Buy
Current Market Cap: $2.81B
Learn more about PRVA stock on TipRanks’ Stock Analysis page.